NASDAQ · Drug Manufacturers - Specialty & Generic
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock
$5.33
-3.96%
NASDAQ: SHPH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
CryptoProwl · May 1, 2026
RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
TMX Newsfile · Mar 27, 2026
Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
TMX Newsfile · Mar 26, 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering
GlobeNewswire · Mar 12, 2026
Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
TMX Newsfile · Mar 6, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.94%
Institutions Held2.99%
Institutions Float Held3.02%
Peer Comparison
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. is led by CEO Christopher Robert Cooper, employs 9 people, headquartered in US, publicly traded since 2022.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock trades at $5.33 with a market capitalization of $3.12M. The stock is valued at a price-to-earnings (P/E) ratio of -0.13, price-to-book of 0.21, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.58 and $55.90, and currently trades 90.5% below its 52-week high.
On profitability, Shuttle Pharmaceuticals Holdings, Inc. generates a return on equity (ROE) of -156.78%, return on capital employed of -58.05%, an operating margin of 0.00%, a net profit margin of 0.00%.